Body mass index (BMI), age at disease onset, disease duration, measured biochemical parameters in serum (iron, transferrin, ferritin) as well as GPX4 and MDA plasma levels were not significantly different between RR and SP MS patients, either in the discovery or in replication group. Here, GPX4 is linked to myeloid sarcoma.